GuavaH: A compendium of host genomic data in HIV biology and disease

Retrovirology

Volumn 11, Issue 1, 2014, Pages

  Bartha, István ^a,b,c   McLaren, Paul J ^a,b,c   Ciuffi, Angela ^a   Fellay, Jacques ^a,b,c   Telenti, Amalio ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

^c SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

Author keywords

Exome analysis; Genome wide association studies; HIV latency; Transcriptome analysis

Indexed keywords

TRANSCRIPTOME;

ARTICLE; CD4+ T LYMPHOCYTE; DATA ANALYSIS; DATA ANALYSIS SOFTWARE; DISEASE COURSE; DNA MICROARRAY; EX VIVO STUDY; EXOME; GENE EXPRESSION PROFILING; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; INFECTION SENSITIVITY; NONHUMAN; PHENOTYPIC VARIATION; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS LATENCY; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REACTIVATION; VIRUS REPLICATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC DATABASE; GENOMIC UTILITY FOR ASSOCIATION AND VIRAL ANALYSIS IN HIV DATABASE; IMMUNE RESPONSE; MICROARRAY ANALYSIS; PHENOTYPE; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS IDENTIFICATION;

COMPUTATIONAL BIOLOGY; GENETIC VARIATION; GENOME, HUMAN; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; TRANSCRIPTOME;

EID: 84894584738     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-11-6     Document Type: Article

References (10)

1. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, Urban TJ, Zhang K, Gumbs CE, Smith JP, et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009, 5:e1000791. 10.1371/journal.pgen.1000791, 2791220, 20041166.
2. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007, 317:944-947. 10.1126/science.1143767, 1991296, 17641165.
3. International HIVCS, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010, 330:1551-1557. 3235490, 21051598.
4. Lane J, McLaren PJ, Dorrell L, Shianna KV, Stemke A, Pelak K, Moore S, Oldenburg J, Alvarez-Roman MT, Angelillo-Scherrer A, et al. A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Hum Mol Genet 2013, 22:1903-1910. 10.1093/hmg/ddt033, 23372042.
5. Bartha I, Carlson JM, Brumme CJ, McLaren PJ, Brumme ZL, John M, Haas DW, Martinez-Picado J, Dalmau J, Lopez-Galindez C, et al. A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control. eLife 2013, 2:e01123. 10.7554/eLife.01123, 3807812, 24171102.
6. MacArthur DG, Balasubramanian S, Frankish A, Huang N, Morris J, Walter K, Jostins L, Habegger L, Pickrell JK, Montgomery SB, et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science 2012, 335:823-828. 10.1126/science.1215040, 3299548, 22344438.
7. Rotger M, Dang KK, Fellay J, Heinzen EL, Feng S, Descombes P, Shianna KV, Ge D, Gunthard HF, Goldstein DB, et al. Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog 2010, 6:e1000781. 10.1371/journal.ppat.1000781, 2829051, 20195503.
8. Mohammadi P, Desfarges S, Bartha I, Joos B, Zangger N, Munoz M, Gunthard HF, Beerenwinkel N, Telenti A, Ciuffi A. 24 hours in the life of HIV-1 in a T cell line. PLoS Pathog 2013, 9:e1003161. 10.1371/journal.ppat.1003161, 3561177, 23382686.
9. Bushman FD, Barton S, Bailey A, Greig C, Malani N, Bandyopadhyay S, Young J, Chanda S, Krogan N. Bringing it all together: big data and HIV research. Aids 2013, 27:835-838. 10.1097/QAD.0b013e32835cb785, 3671485, 23719353.
10. McMichael AJ, McCutchan F. Host genetics and viral diversity: report from a global HIV vaccine enterprise working group. Nat Prec 2010, doi:10.1038/npre.2010.4797.2.